Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
Open Access
- 10 December 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (24), 9400
- https://doi.org/10.3390/ijms21249400
Abstract
Gastric cancer (GC) is a deadly disease with poor prognosis that is characterized by heterogeneity. New classifications based on histologic features, genotypes, and molecular phenotypes, for example, the Cancer Genome Atlas subtypes and those by the Asian Cancer Research Group, help understand the carcinogenic differences in GC and have led to the identification of an Epstein–Barr virus (EBV)-related GC subtype (EBVaGC), providing new indications for tailored treatment and prognostic factors. This article provides a review of the features of EBVaGC and an update on the latest insights from EBV-related research with a particular focus on the strict interaction between EBV infection and the gastric tumor environment, including the host immune response. This information may help increase our knowledge of EBVaGC pathogenesis and the mechanisms that sustain the immune response of patients since this mechanism has been demonstrated to offer a survival advantage in a proportion of patients with GC.This publication has 185 references indexed in Scilit:
- Aging and Immune Function: Molecular Mechanisms to InterventionsAntioxidants and Redox Signaling, 2011
- The Epstein–Barr Virus BART microRNAs target the pro-apoptotic protein BimVirology, 2011
- Epstein-Barr virus-specific methylation of human genes in gastric cancer cellsInfectious Agents and Cancer, 2010
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic LocationGastroenterology, 2009
- Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome AmplificationJournal of Virology, 2009
- Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patientsBritish Journal of Cancer, 2009
- An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survivalThe Journal of Experimental Medicine, 2008
- The Epstein–Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cellsVirology, 2008
- Expression of Viral MicroRNAs in Epstein-Barr Virus-Associated Gastric CarcinomaJournal of Virology, 2007